4.7 Review

Sonodynamic therapy: A potential treatment for atherosclerosis

期刊

LIFE SCIENCES
卷 207, 期 -, 页码 304-313

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2018.06.018

关键词

Atherosclerosis; Sonodynamic therapy (SDT); Ultrasound; Sonosensitizer; Macrophage; Reactive oxygen species (ROS)

资金

  1. National Natural Science Foundation of China [81330003, 81630009, 31571170, 81400247]
  2. Chang Jiang Scholar Program of China [T2011160]

向作者/读者索取更多资源

Atherosclerosis (AS), a chronic arterial disease, is one of the major causes of morbidity and mortality worldwide. Several treatment modalities have been demonstrated to be effective in treating AS; however, the mortality rate due to AS remains high. Sonodynamic therapy (SDT) is a promising new treatment using low-intensity ultrasound in combination with sonosensitizers. Although SDT was developed from photodynamic therapy (PDT), it has a stronger tissue-penetrating capability and exhibits a more focused effect on the target lesional site requiring treatment. Furthermore, SDT has been demonstrated to suppress the formation of atheromatous plaques, and it can increase plaque stability both in vitro and in vivo. In this article, we critically summarize the recent literature on SDT, focusing on its possible mechanism of action as well as the existing and newly discovered sonosensitizers and chemotherapeutic agents for the treatment of AS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

Role of IgE-FcεR1 in Pathological Cardiac Remodeling and Dysfunction

Hongmei Zhao, Hongqin Yang, Chi Geng, Yang Chen, Junling Pang, Ting Shu, Meijun Zhao, Yaqin Tang, Zhiwei Li, Baicun Li, Cuiliu Hou, Xiaomin Song, Aoxue Wu, Xiaoxiao Guo, Si Chen, Bin Liu, Chen Yan, Jing Wang

Summary: The study found that IgE plays a causative role in pathological cardiac remodeling, at least partially through activating IgE-Fc epsilon R1 signaling in cardiomyocytes and cardiac fibroblasts. Therapeutic strategies targeting the IgE-Fc epsilon R1 axis may be effective for managing IgE-mediated cardiac remodeling.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Predictive value of H2FPEF score in patients with heart failure with preserved ejection fraction

Yuxi Sun, Niuniu Wang, Xiao Li, Yanli Zhang, Jie Yang, Gary Tse, Ying Liu

Summary: The H2FPEF score is a useful tool for predicting prognosis in HFpEF patients, with higher scores being associated with higher all-cause mortality and rehospitalization rates.

ESC HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Case Report: Thromboembolism and Hemorrhagic Pericardial Effusion-The Janus Face of Primary Pericardial Angiosarcoma

Fei F. Chen, Shu F. Jiang, Chang Dong, Ying Che, Lin Y. Du, Zhi Y. Li, Zhi Q. Yang, Yi C. Zhao, Ying Liu

Summary: Primary cardiac angiosarcomas, especially those originating in the pericardium, are rare and aggressive tumors with diverse clinical presentations often masked by other comorbidities. This case report presents a patient with both pulmonary thromboembolism and pericardial tamponade ultimately diagnosed with angiosarcoma. The challenging diagnosis of this disease requires multiple imaging modalities and biopsies for accurate diagnosis and effective management.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Chemistry, Multidisciplinary

MK2206 attenuates atherosclerosis by inhibiting lipid accumulation, cell migration, proliferation, and inflammation

Ya-qin Tang, Zhi-wei Li, Yu-fan Feng, Hong-qin Yang, Cui-liu Hou, Chi Geng, Pei-ran Yang, Hong-mei Zhao, Jing Wang

Summary: The study revealed that MK2206 has anti-inflammatory and anti-atherosclerotic potential, reducing vascular inflammation, atherosclerotic lesions, and inhibiting proliferation of vascular smooth muscle cell.

ACTA PHARMACOLOGICA SINICA (2022)

Letter Cardiac & Cardiovascular Systems

Response by Zhao et al to Letter Regarding Article, Role of IgE-FcεRI in Pathological Cardiac Remodeling and Dysfunction

Hongmei Zhao, Chi Geng, Chen Yan, Jing Wang

CIRCULATION (2021)

Meeting Abstract Cardiac & Cardiovascular Systems

Clustering analysis based on automated electrocardiographic measurements to identify prognostically distinct phenotypes in patients hospitalized for heart failure: a retrospective cohort study

J. S. K. Chan, J. Zhou, A. Li, M. Tan, W. T. Wong, A. Ciobanu, A. Gkouziouta, K. Letsas, T. Liu, Y. Liu, Q. Zhang, G. Tse

EUROPEAN HEART JOURNAL (2022)

Article Medical Laboratory Technology

Allergic asthma aggravates angiotensin II-induced cardiac remodeling in mice

C. H. Geng, Y. U. F. A. N. Feng, Y. A. N. G. Yang, H. O. N. G. Q. I. N. Yang, Z. H. I. W. E. I. LI, Y. A. Q. I. N. Tang, J. I. N. G. Wang, H. O. N. G. M. E. Zhao

Summary: Cardiovascular disease, including heart failure (HF), is a leading cause of death globally. This study explored the link between asthma and HF, and found a higher prevalence of HF among asthmatic individuals. In animal models, asthma impaired heart function and aggravated cardiac remodeling. The study also identified the involvement of immunoglobulin E (IgE) and its receptor (Fc epsilon R1) in the adverse effects of asthma on the heart. Blockage of IgE-Fc epsilon R1 prevented asthma-induced decline of cardiac function and alleviated cardiac remodeling. These findings suggest the potential use of anti-IgE therapy in treating asthma complicated with heart conditions.

TRANSLATIONAL RESEARCH (2022)

Article Pharmacology & Pharmacy

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice

Liangqingqing Yin, Jie Bai, Wei-Jia Yu, Ying Liu, Hui-Hua Li, Qiu-Yue Lin

Summary: The adhesion of monocytes to the vascular endothelium is an important factor in inflammatory response and contributes to hypertension and vascular remodeling. The role of VCAM-1 in Ang II-induced hypertension and vascular dysfunction is not well understood. Blocking VCAM-1 with a neutralizing antibody can alleviate these effects and represents a novel therapeutic approach for hypertension.

FRONTIERS IN PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users

Jiandong Zhou, Sharen Lee, Keith Sai Kit Leung, Abraham Ka Chung Wai, Tong Liu, Ying Liu, Dong Chang, Wing Tak Wong, Ian Chi Kei Wong, Bernard Man Yung Cheung, Qingpeng Zhang, Gary Tse

Summary: This study compared the rates of major cardiovascular adverse events between users of sodium-glucose cotransporter-2 inhibitors (SGLT2I) and dipeptidyl peptidase-4 inhibitors (DPP4I) in a Chinese population. The results showed that the use of SGLT2 inhibitors was associated with a significantly lower risk of new-onset heart failure, myocardial infarction, cardiovascular mortality, and all-cause mortality.

ESC HEART FAILURE (2022)

Article Cardiac & Cardiovascular Systems

Effect of angiotensin receptor neprilysin inhibitors on left atrial remodeling and prognosis in heart failure

Yuxi Sun, Shuang Song, Yanli Zhang, Wenqiong Mo, Xinxin Zhang, Ning Wang, Yunlong Xia, Gary Tse, Ying Liu

Summary: This study found that compared to ACEI/ARB, ARNI has greater effects on left atrial reverse remodeling and is associated with a better prognosis in heart failure patients. For patients with mildly abnormal left atrial volume index, ARNI use can significantly reduce mortality.

ESC HEART FAILURE (2022)

Review Cardiac & Cardiovascular Systems

Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction

Huiyu Xiao, Xiaojie Wang, Shuang Li, Ying Liu, Yijie Cui, Xiaoqin Deng

Summary: With the extended overall survival of cancer patients, the cardiovascular toxicity associated with oncology drug therapy and radiotherapy has become a focus of attention. Early identification methods for cancer treatment-related cardiac dysfunction (CTRCD) include imaging examinations and blood biomarkers. Common tumor therapies that cause CTRCD are chemotherapy, targeted therapy, immunotherapy, and radiotherapy, while emerging biomarkers show potential in predicting CTRCD.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Fragmented QRS Is Independently Predictive of Long-Term Adverse Clinical Outcomes in Asian Patients Hospitalized for Heart Failure: A Retrospective Cohort Study

Jeffrey Shi Kai Chan, Jiandong Zhou, Sharen Lee, Andrew Li, Martin Tan, Keith Sai Kit Leung, Kamalan Jeevaratnam, Tong Liu, Leonardo Roever, Ying Liu, Gary Tse, Qingpeng Zhang

Summary: fQRS in heart failure patients is an independent predictor of cardiovascular mortality, VA, and SCD. The presence of fQRS in more than 2 contiguous leads increases the risk of SCD. fQRS remains predictive of VA and SCD in heart failure patients without ischemic heart disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Letter Cardiac & Cardiovascular Systems

High visit-to-visit cholesterol variability predicts heart failure and adverse cardiovascular events: a population-based cohort study

Jeffrey Shi Kai Chan, Danish Iltaf Satti, Yan Hiu Athena Lee, Jeremy Man Ho Hui, Teddy Tai Loy Lee, Oscar Hou In Chou, Abraham Ka Chung Wai, Ana Ciobanu, Ying Liu, Tong Liu, Leonardo Roever, Giuseppe Biondi-Zoccai, Qingpeng Zhang, Bernard Man Yung Cheung, Jiandong Zhou, Gary Tse

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Review Pharmacology & Pharmacy

Immunomodulatory Treatment Strategies Targeting B Cells for Heart Failure

Xinxin Zhang, Yuxi Sun, Ning Wang, Yanli Zhang, Yunlong Xia, Ying Liu

Summary: Cardio-oncology is a nascent specialty that aims to address the cardiovascular complications of cancer therapies. Some anti-tumor drugs have cardioprotective effects in addition to their cancer treatment properties. B cells participate in and promote the progression of cardiovascular diseases, suggesting novel immunomodulatory therapeutic strategies targeting B cells and their products.

FRONTIERS IN PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p

Hongmei Zhao, Hongqin Yang, Chi Geng, Yang Chen, Yaqin Tang, Zhiwei Li, Junling Pang, Ting Shu, Yu Nie, Yongshuo Liu, Kegang Jia, Jing Wang

Summary: Research shows that elevated IgE promotes pathological cardiac fibrosis by modulating miR-486a-5p and downstream factors, such as Smad1, providing new targets for intervention in pathological cardiac fibrosis.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Targeting the chromatin remodeling protein BRG1 in liver fibrosis: Mechanism and translational potential

Yuwen Zhu, Yan Guo, Yujia Xue, Anqi Zhou, Ying Chen, Yifei Chen, Xiulian Miao, Fangqiao Lv

Summary: BRG1 plays an important role in HSC-myofibroblast transition and targeting it could be a reasonable strategy for liver fibrosis intervention.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

DCLK1 and its oncogenic functions: A promising therapeutic target for cancers

Liu Ye, Beibei Liu, Jingling Huang, Xiaolin Zhao, Yuan Wang, Yungen Xu, Shuping Wang

Summary: Doublecortin-like kinase 1 (DCLK1) is a significant prooncogenic factor that is strongly associated with the malignant progression and clinical prognosis of various cancers. DCLK1 plays important roles in stem cell marker regulation, tumor cell reprogramming, and immune evasion. However, the exact biological functions of DCLK1, especially the disparities between its alpha- and beta-form transcripts in cancer progression, remain ambiguous.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Potential role of bile acids in the pathogenesis of necrotizing enterocolitis

Jiahui Yang, Xiaoyu Chen, Tianjing Liu, Yongyan Shi

Summary: This article reviews the role of bile acids in necrotizing enterocolitis (NEC) and their potential therapeutic value. The dysregulation of bile acids is associated with intestinal injury, and inflammatory factors in the liver also play a crucial role in regulating bile acid transport. The bile acid metabolic pathway is important for regulating intestinal microbiota, cell proliferation, and barrier protection.

LIFE SCIENCES (2024)

Review Medicine, Research & Experimental

Review on chronic metabolic diseases surrounding bile acids and gut microbiota: What we have explored so far

Zhenzheng Zhu, Yuemiao Xu, Yuwei Xia, Xinru Jia, Yixin Chen, Yuyue Liu, Leyin Zhang, Hui Chai, Leitao Sun

Summary: Bile acid, as the final product of cholesterol breakdown, plays a complex regulatory and signaling role in human metabolism. Research suggests that it has the potential to enhance metabolism and regulate chronic metabolic diseases through various pathways. The interaction between bile acid and gut microbiota is also of great significance.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Metabolomics study reveals increased deoxycholic acid contributes to deoxynivalenol-mediated intestinal barrier injury

Xin He, Hong-Xu Zhou, Xian Fu, Kai-Di Ni, Ai-Zhi Lin, Ling-Tong Zhang, Hou-Hua Yin, Qing Jiang, Xue Zhou, Yi-Wen Meng, Jun-Yan Liu

Summary: DON exposure causes an increase in deoxycholic acid (DCA), which contributes to intestinal injury. DCA may be a potential therapeutic target for DON enterotoxicity.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

TET1-mediated epigenetic regulation of tumor necrosis factor-α in trigeminal ganglia contributes to chronic temporomandibular joint pain

Zhitao Wang, Heng Ma, Abdul Nasir, Sufang Liu, Zhisong Li, Feng Tao, Qian Bai

Summary: This study reveals the involvement of TET1-mediated epigenetic regulation in chronic TMJ pain through trigeminal TNF alpha signaling.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Targeting HIF-1α alleviates the inflammatory responses and rebuilds the CD4+ T cell subsets balance in the experimental autoimmune myasthenia gravis inflammation model via regulating cellular and humoral immunity

Lu Yu, Hao Ran, Yaru Lu, Qian Ma, Huan Huang, Weibin Liu

Summary: This study found that the HIF-1 alpha inhibitor BAY 87-2243 can alleviate the symptoms of the Experimental Autoimmune Myasthenia Gravis (EAMG) inflammation model. BAY 87-2243 can restore the balance of CD4(+)T cell subsets, reduce the production of pro-inflammatory cytokines, and act as both an immune imbalance regulator and anti-inflammatory.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Evidence for the involvement of TRPV2 channels in the modulation of vascular tone in the mouse aorta

Alex Peralvarez-Marin, Montse Sole, Judith Serrano, Alice Taddeucci, Belen Perez, Clara Penas, Gemma Manich, Marcel Jimenez, Pilar D'Ocon, Francesc Jimenez-Altayo

Summary: This study provides the first evidence that TRPV2 channels may modulate vascular tone by balancing opposing inputs from the endothelium and smooth muscle, leading to net vasodilation. The amplification of TRPV2 channel-induced activity by NO emphasizes the pathophysiological relevance of these findings.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: Prognosis and therapeutic molecules

Amin Ullah, Jing Zhao, Jiakun Li, Rajeev K. Singla, Bairong Shen

Summary: Gastric cancer is the fifth-most prevalent and second-most deadly cancer worldwide. Late onset of symptoms makes early detection important. CXC chemokines play an important role in the pathological process of gastric cancer, but their exact role in diagnosis and prognosis is not fully understood. Inhibiting CXC chemokines shows promise as a targeted therapy.

LIFE SCIENCES (2024)

Article Medicine, Research & Experimental

Trigonelline mitigates bleomycin-induced pulmonary inflammation and fibrosis: Insight into NLRP3 inflammasome and SPHK1/S1P/Hippo signaling modulation

Menna S. Zeyada, Salma M. Eraky, Mamdouh M. El-Shishtawy

Summary: The current study demonstrates the prophylactic and antifibrotic effects of Trig against BLM-induced PF by targeting multiple signaling pathways. The combination of Trig and Pirf may be a promising approach to enhance Pirf's anti-fibrotic effect.

LIFE SCIENCES (2024)